1283 Recruiting Trials

Clinical Trials
in Alabama

Browse 1283 recruiting clinical trials currently enrolling participants in Alabama. Search by condition to find trials you may qualify for, at no cost.

Showing 15 of 1283 recruiting trials in Alabama

Collection and Storage of Tissue and Blood Samples From Patients With Cancer
N/A Birmingham, Alabama +4 sites · Malignant Solid Neoplasm, Hematopoietic and Lymphatic System Neoplasm
Recruiting
Testing the Effectiveness of Two Immunotherapy Drugs (Nivolumab and Ipilimumab) With One Anti-cancer Targeted Drug (Cabozantinib) for Rare Genitourinary Tumors
PHASE2 Birmingham, Alabama +4 sites · Sarcomatoid Renal Cell Carcinoma, Stage IV Renal Cell Cancer AJCC v8
Recruiting
Testing Early Treatment for Patients With High-Risk Chronic Lymphocytic Leukemia (CLL) or Small Lymphocytic Leukemia (SLL), EVOLVE CLL/SLL Study
PHASE3 Birmingham, Alabama +4 sites · Chronic Lymphocytic Leukemia, Small Lymphocytic Lymphoma
Recruiting
A Motion Exergaming Approach for Symptom Management: HNC
NA Birmingham, Alabama · Head and Neck Cancer
Recruiting
A Study of ART0380 for the Treatment of Advanced or Metastatic Solid Tumors
PHASE1 Birmingham, Alabama +4 sites · Ovarian Cancer, Endometrial Cancer
Recruiting
A Study to Compare Standard Therapy to Treat Hodgkin Lymphoma to the Use of Two Drugs, Brentuximab Vedotin and Nivolumab
PHASE3 Birmingham, Alabama +4 sites · Lugano Classification Limited Stage Hodgkin Lymphoma AJCC v8
Recruiting
Adding an Immunotherapy Drug, MEDI4736 (Durvalumab), to the Usual Chemotherapy Treatment (Paclitaxel, Cyclophosphamide, and Doxorubicin) for Stage II-III Breast Cancer
PHASE3 Birmingham, Alabama +4 sites · Anatomic Stage III Breast Cancer AJCC v8, Anatomic Stage II Breast Cancer AJCC v8
Recruiting
Testimonials and Navigation in Rheumatology
NA Birmingham, Alabama +3 sites · Autoimmune Diseases, Rheumatologic Disease
Recruiting
Prevention/Reduction of ASRs and PTSD to Sustain Civilian Performance With Sublingual Cyclobenzaprine HCl (TNX-102 SL)
PHASE2 Birmingham, Alabama +4 sites · Acute Stress Reaction, Neurocognitive Function
Recruiting
Dabrafenib and Trametinib for BRAF V600 Mutant Low-Grade Gliomas
PHASE2 Birmingham, Alabama +4 sites · Low-grade Glioma, Low Grade Glioma of Brain
Recruiting